Research Article
Analysis of the Distribution and Antibiotic Resistance of Pathogens Causing Infections in Hospitals from 2017 to 2019
Table 21
Analysis of multiple drug resistance rate of CREs in 2019.
| | | Drugs | Drug resistance rate (%) |
| | CREs | Ampicillin-sulbactam | 97.1 | | | Imipenem | 88.9 | | | Ceftriaxone | 84.9 | | | Ertapenem | 83.6 | | | Ceftazidime | 82.7 | | | Nitrofurantoin | 79.4 | | | Ciprofloxacin | 78.9 | | | Aztreonam | 77.3 | | | Levofloxacin | 76.8 | | | Cefepime | 75.8 | | | Piperacillin-tazobactam | 74.5 | | | Cefoperazone-sulbactam | 70.4 | | | Gentamicin | 53.5 | | | Tobramycin | 50.0 | | | Cotrimoxazole | 43.3 | | | Amikacin | 31.6 | | | Tigecycline | 0.0 |
|
|
